Clinical Trial Update: Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dupilumab for chronic inducible cold urticaria in patients not adequately controlled by H1 antihistamines has completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inducible Cold Urticaria

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Cold Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2024-02-21